Immunic regains compliance with Nasdaq minimum bid price requirement

IMMUNIC, INC.

Nasdaq notified Immunic on Mar 27, 2026 it regained compliance with minimum bid price rule (Rule 5550(a)(2)).
Closing bid price was $1.00 or higher for 20 consecutive business days from Feb 27 to Mar 26, 2026.
Compliance matter is now closed; no further action required to maintain Nasdaq Capital Market listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.